Fair organ distribution requires balancing competing priorities: how sick someone is right now, how long they’ve been waiting, and how many years of life a transplant will add. No single principle satisfies everyone, which is why allocation systems combine multiple factors and weight them differently depending on the organ. With over 103,000 people on the U.S. transplant waiting list and roughly 48,000 transplants performed in 2024, every allocation decision means someone else keeps waiting.
The debate over fairness centers on a core tension. Should organs go to the sickest person, the one who will benefit the longest, or the one who has waited the most time? Each approach reflects a legitimate moral claim, and real-world systems try to honor all three at once.
The Two Big Principles in Conflict
Most allocation frameworks draw from two ethical goals. The first is medical urgency: give the organ to the person closest to death. This is a rescue principle. It treats the transplant list like an emergency room, prioritizing whoever is in the most danger right now. Heart and liver allocation in the U.S. lean heavily on this idea, because patients with failing hearts or livers often cannot survive long without a transplant.
The second goal is utility: get the most total benefit from each donated organ. This means considering how long the transplant is likely to work and how many quality years of life it will produce. A kidney given to a 25-year-old with no other health problems will, on average, function far longer than the same kidney given to a 70-year-old with diabetes. Kidney allocation in the U.S. incorporates this principle explicitly through scoring systems that estimate how long a recipient will benefit from the transplant.
A third principle, equity, cuts across both. It asks whether the system treats all patients fairly regardless of race, income, geography, or age. Pure urgency and pure utility can both produce inequitable outcomes. Someone with better access to healthcare may get listed sooner, giving them a head start on waiting time. Someone in a region with more donors may get an organ faster than an equally sick patient elsewhere. Fairness requires actively checking for these gaps.
How the U.S. System Actually Works
The U.S. uses different criteria for different organs, because the medical realities vary. Blood type and organ size matter for every transplant. Beyond that, the factors diverge.
For kidneys, the system weighs waiting time, how well the donor and recipient immune systems match, whether the patient is a child, distance from the donor hospital, whether the patient previously donated a living organ to someone else, and estimated survival benefit. Kidneys are unique in that patients can survive on dialysis while waiting, so pure urgency matters less than it does for hearts or livers. Instead, the system tries to match organ longevity with recipient longevity. Every donated kidney receives a score from 0 to 100 estimating how long it will function compared to other kidneys, based on the donor’s age, weight, cause of death, and medical history. Every candidate receives a parallel score estimating how long they’ll benefit from a transplant, based on their age, time on dialysis, prior transplants, and diabetes status. The longest-lasting kidneys (those scoring 20 or below) are first offered to the patients expected to benefit the longest (also scoring 20 or below). If no one in that group accepts the kidney, it’s offered to anyone who matches.
For hearts, medical urgency and distance from the donor hospital are the dominant factors. Hearts can only survive outside the body for a few hours, so geography is a hard constraint. The sickest patients, those on mechanical support or in intensive care, are prioritized.
For livers, urgency also drives allocation. Each candidate’s severity is calculated from blood test results that reflect how well the liver and kidneys are functioning, along with factors like age and sodium levels. The higher the score, the sicker the patient, and the higher their priority.
Why Children Get Special Priority
Federal law directs the U.S. allocation system to address the unique needs of children. The ethical case for pediatric priority rests on several arguments. Children with organ failure face diminished quality of life during critical developmental years. They often need size-matched organs, which limits the pool of donors available to them. And across the full population of transplant recipients, younger patients tend to have lower mortality rates and longer survival after transplant, meaning pediatric priority often aligns with the utility principle too.
That said, the case isn’t universal across all organs. Some very young children pose surgical challenges, and adolescents actually have higher rejection rates than adults for kidney transplants. The system applies pediatric priority differently depending on the organ type and the clinical context, rather than using a blanket rule.
How Other Countries Handle It Differently
Comparing systems reveals the trade-offs. Eurotransplant, which coordinates allocation across eight European countries, places much heavier emphasis on immune system matching for kidneys. The U.S. system considers only one category of immune markers, while Eurotransplant weighs three categories equally. Better matching generally reduces the chance of rejection, but insisting on a close match can mean longer waits and longer time that the organ spends in transit.
Eurotransplant also runs a seniors program: kidneys from donors over 65 go to recipients in the same age group, skipping the usual matching requirements entirely. The logic is practical. Older recipients are unlikely to outlive even a less-than-perfect kidney, so minimizing the time between retrieval and transplant matters more than finding an ideal match. The U.S. takes a different approach, defining expanded-criteria donors (older donors or those with certain health conditions) and creating a separate, faster track for patients who agree in advance to accept those organs.
For highly sensitized patients, those whose immune systems react against a wide range of donors, Eurotransplant runs a program that identifies the specific donor types a patient can tolerate and gives those patients priority access when a compatible organ becomes available. The U.S. system also gives priority to sensitized patients, but uses a different method to measure and address the problem.
Geographic Fairness Remains Contentious
One of the most debated aspects of organ allocation is geography. Organs have been historically offered first to patients near the donor hospital, then regionally, then nationally. This makes medical sense for organs that deteriorate quickly outside the body, like hearts. But for kidneys, which tolerate longer transport times, strict local preference can create stark inequities. A patient in a region with high donation rates might receive an organ in two years, while someone equally sick in a low-donation area waits five or more.
The U.S. system has been moving toward a “continuous distribution” model that replaces hard geographic boundaries with a sliding scale. Distance still matters, but it’s weighed against medical urgency, expected benefit, and other factors rather than serving as an absolute cutoff. The goal is to reduce the geographic lottery without ignoring the real constraint that organs can only survive so long outside the body.
Racial and Socioeconomic Disparities
Even a technically fair allocation formula can produce unequal outcomes if access to the system itself is unequal. Black patients have historically been less likely to receive a kidney transplant compared to white patients. Some of this gap occurs before a patient ever reaches the waitlist: differences in referral rates, insurance coverage, and the evaluation process all affect who gets listed and when. Hispanic patients have also historically had lower transplant rates after being waitlisted.
A major overhaul of the kidney allocation system in 2014 addressed one piece of this problem by crediting patients for time spent on dialysis before they were formally added to the waitlist. Since Black patients were disproportionately likely to experience long delays between starting dialysis and being listed, this change helped narrow the gap. Early data showed that racial disparities in transplant rates among waitlisted patients were at least temporarily eliminated following the policy change, though the system continues to be monitored for new patterns of inequity.
What “Fair” Actually Requires
No allocation system can be perfectly fair, because the core ethical principles point in different directions. Prioritizing the sickest patients means some organs go to people with lower chances of long-term survival. Maximizing total life-years saved means younger, healthier patients consistently move ahead of older or sicker ones. Strict equality of waiting time ignores the fact that some patients are days from death while others are stable.
The most defensible systems are transparent about these trade-offs and combine multiple principles rather than relying on just one. They weight urgency heavily for organs where patients die quickly without a transplant, incorporate expected benefit where waiting alternatives like dialysis exist, give children priority because organ failure during development carries unique harms, and actively monitor for disparities that the formula alone can’t fix. The question isn’t whether one principle is right and the others wrong. It’s how much weight each one deserves, and that balance shifts depending on the organ, the patient population, and the values a society chooses to prioritize.